Cell Constraint & Cancer develops a disruptive innovation in Oncology: 2 medical devices. Proof of Concept in 2012. P. of Efficacy in 13/14.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free